NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of NET Power Inc. (NYSE: NPWR, NPWR.WS) between June 9, 2023 and March 7, 2025, both dates inclusive (the “Class Period”), of the important June 17, 2025 lead plaintiff deadline. SO WHAT: If you purchased NET Power securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WH ...

Key Takeaways Visa saw 8% Y/Y growth in Q2 fiscal 2025 payments volume and 9% growth in processed transactions. V is deepening fintech ties via an extended TabaPay deal and new Visa Direct account and wallet features. Visa launched a Commercial Integrated Partners program to enhance fintech connectivity and services.Visa Inc. (V) focuses on sharpening its edge in the digital payments space through robust and growing fintech partnerships, acquisitions and platform building. It is redefining its role from a ...

Key Takeaways Rigetti posted Q1 revenue of $1.5M, missing estimates and trailing peers like IonQ and D-Wave. RGTI still relies on short-term government contracts, limiting revenue visibility and investor confidence. Despite tech gains with Ankaa-3, Rigetti projects a 3-5 year wait for real commercial traction.Rigetti Computing (RGTI) posted an impressive year-to-date gain, but a closer look at recent developments reveals growing competitive pressure. Recently, industry players like IonQ (IONQ) and D-Wave ...

“Hurricane Jamie” lost one of his rainmakers.JPMorgan managing director Matthew Demko quit the Jamie Dimon-led bank to join Ryan Specialty Group, an insurance broker and underwriter founded by billionaire Patrick G. Ryan, The Post has learned.The investment banker’s last day of employment with the US financial giant was Monday, according to his broker profile posted on the website of US regulator FINRA, but it is yet to updated with his new job. 3 Jamie Demko, 42, has been with JPMorgan for his entire car ...

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. ("Rocket" or the "Company") (NASDAQ: RCKT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who were adversely affected by alleged securities fraud between February 27, 2025 and May 26, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/rocket-pharmaceuti ...

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in UroGen Pharma Ltd. ("UroGen Pharma Ltd." or the "Company") (NASDAQ: URGN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of UroGen Pharma Ltd. investors who were adversely affected by alleged securities fraud between July 27, 2023 and May 15, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/urogen-p ...

Core Viewpoint - A class action securities lawsuit has been filed against Iovance Biotherapeutics, Inc. for alleged securities fraud affecting investors between May 9, 2024, and May 8, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Iovance provided misleading positive statements while concealing material adverse facts about its growth potential, particularly its inability to generate demand for its treatments [2]. - On July 25, 2024, Iovance announced a reduction in its revenue guidance for fiscal year 2024, attributing this to maintenance issues, lower-than-expected Proleukin sales, and a variable pace of treatment initiation at approved centers [2]. - Following the announcement, Iovance's stock price plummeted from $3.17 per share on May 8, 2025, to $1.75 per share on May 9, 2025, marking a decline of approximately 44.8% in one day [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified period have until July 14, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Core Viewpoint - International Consolidated Airlines Group S.A. (IAG) is undervalued in the U.S. investing circle, likely due to its lack of recognition among American investors [1] Company Overview - IAG is an OTC-traded European airline group that owns several well-known airlines [1] Investment Potential - The undervaluation presents a potential investment opportunity for investors who are willing to explore lesser-known stocks [1]

Core Insights - Werner Enterprises (WERN) is currently facing multiple challenges, making it an unattractive investment option [1] Earnings Estimates - The Zacks Consensus Estimate for WERN's second-quarter 2025 earnings has decreased by 78.5% over the past 60 days, while the full-year 2025 earnings estimate has been revised down by 65.8% in the same period, indicating a lack of confidence from brokers [2][5] - For second-quarter 2025, WERN's earnings are expected to decline by 64.71% year over year, and for the full year, a decrease of 24.53% year over year is anticipated [7] Price Performance - WERN's stock has declined by 23.5% year-to-date, underperforming the transportation-truck industry's decline of 16.1% [5][8] - The company's earnings surprise history is poor, having missed earnings estimates in the past four quarters with an average miss of 79.95% [6][5] Revenue Trends - In the first quarter of 2025, WERN reported revenues of $712.11 million, falling short of the Zacks Consensus Estimate of $746.8 million, and representing a 7% year-over-year decline [8] Industry Challenges - The trucking industry, including WERN, is facing a persistent driver shortage, complicating recruitment as older drivers retire and younger generations are less attracted to low-paying jobs [9] - The industry has a Zacks Industry Rank of 234 out of 250, placing it in the bottom 4% of Zacks industries, which negatively impacts stock performance [10]

Core Viewpoint - Nathan's Famous, Inc. has demonstrated strong financial performance for fiscal year 2025, with significant increases in revenue and net income, leading to a positive stock performance compared to the S&P 500 index [1][2]. Financial Performance - For the fiscal year ended March 30, 2025, Nathan's Famous reported revenues of $148.2 million, a 6.9% increase from $138.6 million in fiscal 2024 [2]. - Net income rose 22.5% to $24 million from $19.6 million in the prior year [2]. - Earnings per diluted share (EPS) grew 22.3% to $5.87 from $4.80 a year ago [2]. - Adjusted EBITDA improved 12.5% to $39.2 million from $34.8 million in fiscal 2024 [2]. - For the fourth quarter of fiscal 2025, revenue grew 6.2% to $30.8 million from $28.9 million [2]. - Net income for the quarter was $4.2 million, an 8.3% year-over-year increase from $3.9 million [2]. Segment Performance - Branded Product Program revenues climbed 6.2% to $91.8 million in fiscal 2025 from $86.5 million in fiscal 2024, driven by a 1.2% increase in volume of hot dogs sold and a 5% increase in average selling price [3]. - Product Licensing revenue grew 11.4% to $37.4 million from $33.6 million, with Smithfield Foods contributing significantly [4]. - Restaurant Operations revenue saw a 2.4% increase to $16.9 million from $16.5 million, with segment income from operations rising 46.4% to $2.4 million from $1.7 million [5]. Key Business Metrics - Franchise Operations posted revenues of $4.1 million in fiscal 2025, down 4.8% from $4.4 million a year earlier [7]. - Advertising fund revenue remained stable at around $2.07 million in fiscal 2025 compared with $2.08 million in fiscal 2024 [8]. Management Commentary - Management emphasized the strength of its multi-channel business model, particularly the stable, high-margin licensing streams and the adaptability of the Branded Product Program [9]. - Strategic pricing and disciplined cost control helped mitigate the impact of ongoing beef cost inflation [10]. Dividend Declaration - In light of strong fiscal 2025 performance, Nathan's Famous' board of directors declared a quarterly dividend of $0.50 per share effective June 10, 2025, signaling continued confidence in the company's cash flow and future earnings stability [11]. Influencing Factors - Nathan's Famous faced headwinds in commodity costs, especially from beef, with prices rising 7% in fiscal 2025 [12]. - Labor inflation persisted, notably in New York, where the minimum wage rose from $16.00 to $16.50 per hour as of January 1, 2025 [13]. Future Outlook - Nathan's Famous did not provide formal financial guidance for fiscal 2026 but expressed confidence in continued growth across its licensing and branded product channels [14]. - The company reaffirmed its long-term manufacturing and distribution agreements, including the pivotal licensing partnership with Smithfield Foods, contracted through March 2032 [15].